You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
The N-acetyltransferase 2 (NAT2) phase II drug metabolizing enzyme is primarily expressed in liver and gut tissue and is one of the most extensively studied enzymes for pharmacogenomic variation.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
